Silvercrest Asset Management Group LLC cut its holdings in shares of STERIS plc (NYSE:STE – Free Report) by 12.6% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 13,157 shares of the medical equipment provider’s stock after selling 1,892 shares during the period. Silvercrest Asset Management Group LLC’s holdings in STERIS were worth $2,958,000 as of its most recent SEC filing.
Other institutional investors also recently bought and sold shares of the company. First Personal Financial Services acquired a new stake in STERIS in the 1st quarter worth about $25,000. J.Safra Asset Management Corp boosted its holdings in STERIS by 77.9% in the 1st quarter. J.Safra Asset Management Corp now owns 121 shares of the medical equipment provider’s stock worth $27,000 after buying an additional 53 shares during the last quarter. Quent Capital LLC boosted its holdings in STERIS by 112.7% in the 1st quarter. Quent Capital LLC now owns 134 shares of the medical equipment provider’s stock worth $30,000 after buying an additional 71 shares during the last quarter. VisionPoint Advisory Group LLC acquired a new stake in STERIS in the 4th quarter worth about $34,000. Finally, Headlands Technologies LLC acquired a new stake in STERIS in the 1st quarter worth about $36,000. 94.69% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
Several equities research analysts recently issued reports on STE shares. JMP Securities reiterated a “market outperform” rating and issued a $265.00 price objective on shares of STERIS in a report on Friday. StockNews.com raised shares of STERIS from a “hold” rating to a “buy” rating in a research note on Saturday, June 15th. Piper Sandler reissued a “neutral” rating and issued a $225.00 target price (up from $220.00) on shares of STERIS in a research note on Friday, May 10th. Finally, Needham & Company LLC reissued a “hold” rating on shares of STERIS in a research note on Friday, May 10th. Three equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $241.60.
STERIS Trading Up 0.6 %
Shares of STE stock traded up $1.53 during trading on Tuesday, hitting $237.85. 264,414 shares of the stock traded hands, compared to its average volume of 479,969. The firm has a market capitalization of $23.51 billion, a P/E ratio of 62.45 and a beta of 0.83. The company has a debt-to-equity ratio of 0.49, a current ratio of 3.08 and a quick ratio of 2.36. The firm’s fifty day moving average price is $223.30 and its 200-day moving average price is $221.93. STERIS plc has a 52-week low of $195.47 and a 52-week high of $254.00.
STERIS (NYSE:STE – Get Free Report) last released its quarterly earnings results on Wednesday, May 8th. The medical equipment provider reported $2.58 EPS for the quarter, beating the consensus estimate of $2.41 by $0.17. The firm had revenue of $1.42 billion for the quarter, compared to analyst estimates of $1.41 billion. STERIS had a net margin of 6.95% and a return on equity of 13.73%. The business’s revenue for the quarter was up 10.8% compared to the same quarter last year. During the same quarter in the previous year, the company earned $2.30 EPS. As a group, research analysts forecast that STERIS plc will post 9.25 earnings per share for the current fiscal year.
STERIS Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Wednesday, June 26th. Stockholders of record on Wednesday, June 12th were given a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a dividend yield of 0.87%. The ex-dividend date was Wednesday, June 12th. STERIS’s payout ratio is presently 54.45%.
Insider Activity
In other STERIS news, VP Renato Tamaro sold 1,154 shares of the business’s stock in a transaction that occurred on Thursday, May 16th. The stock was sold at an average price of $231.64, for a total value of $267,312.56. Following the sale, the vice president now owns 6,677 shares of the company’s stock, valued at $1,546,660.28. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other STERIS news, VP Renato Tamaro sold 1,154 shares of the business’s stock in a transaction that occurred on Thursday, May 16th. The stock was sold at an average price of $231.64, for a total value of $267,312.56. Following the sale, the vice president now owns 6,677 shares of the company’s stock, valued at $1,546,660.28. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Jacqueline B. Kosecoff sold 4,584 shares of the business’s stock in a transaction that occurred on Monday, May 13th. The shares were sold at an average price of $231.53, for a total value of $1,061,333.52. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 7,762 shares of company stock valued at $1,798,477. 1.14% of the stock is currently owned by company insiders.
About STERIS
STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.
Featured Articles
- Five stocks we like better than STERIS
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- AbbVie Analysts Lead the Stock Higher as Humira Worries Recede
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Harley-Davidson Stock Revs Up With Billion Dollar Buyback Program
- Buy P&G Now, Before It Sets A New All-Time High
- Cruise Line Stock Sinks Despite Beating EPS and Raised Guidance
Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for STERIS plc (NYSE:STE – Free Report).
Receive News & Ratings for STERIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS and related companies with MarketBeat.com's FREE daily email newsletter.